Global Health Technologies Coalition Global Health Technologies Coalition
  • Why R&D
  • R&D Facts
  • In Your State
  • Solutions
  • Breakthroughs Blog
  • News & Events
  • Resources
  • About Us
Stay Informed

Breakthroughs Blog

Breakthroughs brings you stories of bright ideas and bold innovations in global health.

From the Breakthroughs Blog: Tuberculosis

Research Roundup: Countries sign on to global vaccine initiative, scientists call for COVID-19 challenge trials, and a new TB test profiles drug resistance
PATH/Aaron Joel Santos
July 20, 2020

Research Roundup: Countries sign on to global vaccine initiative, scientists call for COVID-19 challenge trials, and a new TB test profiles drug resistance

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Anna Kovacevich GHTC
Read more
Research Roundup: New TB drug regimen for drug-resistant infections, Gates Foundation to fund study for coronavirus cure, and long-acting treatment for HIV
PATH/Doune Porter
March 9, 2020

Research Roundup: New TB drug regimen for drug-resistant infections, Gates Foundation to fund study for coronavirus cure, and long-acting treatment for HIV

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Ansley Kahn
GHTC
Read More
Research Roundup: HIV vaccine candidate fails, R&D for infectious diseases reaches record high, and study documents first case of coronavirus spread by asymptomatic person
PATH/Matthew Dakin
February 3, 2020

Research Roundup: HIV vaccine candidate fails, R&D for infectious diseases reaches record high, and study documents first case of coronavirus spread by asymptomatic person

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Ansley Kahn
GHTC
Read More
Research Roundup: Gates Research Institute to develop TB vaccine, scientists begin work on vaccine for new coronavirus, and world is reliant on handful of companies to combat AMR
PATH/Nguyen Phu Cuong
January 27, 2020

Research Roundup: Gates Research Institute to develop TB vaccine, scientists begin work on vaccine for new coronavirus, and world is reliant on handful of companies to combat AMR

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Ansley Kahn
GHTC
Read More
Research Roundup: New drug push for three tropical diseases, new injection method improves TB vaccine efficacy, and breakthrough in developing antimalarials
PATH/Patrick McKern
January 6, 2020

Research Roundup: New drug push for three tropical diseases, new injection method improves TB vaccine efficacy, and breakthrough in developing antimalarials

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Ansley Kahn
GHTC
Julien Rashid GHTC
Read More
Research Roundup: GSK seeks licensing for child-friendly HIV pill, reports say TB R&D funding still falling short, and Gavi to stockpile Ebola vaccines
PATH/Evelyn Hockstein
December 16, 2019

Research Roundup: GSK seeks licensing for child-friendly HIV pill, reports say TB R&D funding still falling short, and Gavi to stockpile Ebola vaccines

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Ansley Kahn
GHTC
Read More
A year in review: The global health innovation stories that shaped 2019
PATH/Gabe Bienczycki
December 13, 2019

A year in review: The global health innovation stories that shaped 2019

As the year comes to a close, we are taking a look back at the top global health innovation stories and news that shaped 2019.

Read More
Research Roundup: New Zika blood test, TB vaccine shows sustained protection, first Lassa fever vaccine set for trial by year's end
PATH/Satvir Malhotra
November 4, 2019

Research Roundup: New Zika blood test, TB vaccine shows sustained protection, first Lassa fever vaccine set for trial by year's end

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Ansley Kahn
GHTC
Read More
Play: TRICK or TREATment?
October 21, 2019

Play: TRICK or TREATment?

To enjoy a bit of fun and mischief this Halloween, we’ve created a game, TRICK or TREATment, to test our readers’ knowledge of global health technologies.

Marissa Chmiola GHTC
Ansley Kahn
GHTC
Read More
Research Roundup: Merck Ebola vaccine approved by European regulators, TB funding gap persists, and new NTD detected in Brazil
PATH/Wendy Stone
October 21, 2019

Research Roundup: Merck Ebola vaccine approved by European regulators, TB funding gap persists, and new NTD detected in Brazil

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Ansley Kahn
GHTC
Read More
Research Roundup: Global Fund replenishment, FDA allows marketing of first rapid Ebola test, and NIH to launch influenza vaccine research centers
PATH/Satvir Malhotra
October 14, 2019

Research Roundup: Global Fund replenishment, FDA allows marketing of first rapid Ebola test, and NIH to launch influenza vaccine research centers

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Ansley Kahn
GHTC
Read More
Research Roundup: 'Highly effective' way to kill malaria parasite, a mobile program to get TB patients to take their pills, and radiating mosquitoes to stop dengue fever outbreak
PATH/Patrick McKern
September 9, 2019

Research Roundup: 'Highly effective' way to kill malaria parasite, a mobile program to get TB patients to take their pills, and radiating mosquitoes to stop dengue fever outbreak

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Ansley Kahn
GHTC
Read More
Research Roundup: The first chlamydia vaccine passed a major test, a new drug approved for drug-resistant tuberculosis, and two new Ebola treatments prove highly effective in the DRC
PATH/Matthew Dakin
August 19, 2019

Research Roundup: The first chlamydia vaccine passed a major test, a new drug approved for drug-resistant tuberculosis, and two new Ebola treatments prove highly effective in the DRC

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Ansley Kahn
GHTC
Read More
Research Roundup: Rotavirus vaccine may help protect against Type 1 diabetes, 1 million child-friendly TB courses ordered since 2016, and Trump orders agencies to trim advisory panels
PATH/Gabe Bienczyckic
June 24, 2019

Research Roundup: Rotavirus vaccine may help protect against Type 1 diabetes, 1 million child-friendly TB courses ordered since 2016, and Trump orders agencies to trim advisory panels

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Ansley Kahn
GHTC
Read More
Research Roundup: FDA advisory panel recommends approval of TB Alliance's TB treatment, innovation in women's health, and British syringe-free vaccine maker set to shake up the industry
PATH/Matthew Dakin
June 10, 2019

Research Roundup: FDA advisory panel recommends approval of TB Alliance's TB treatment, innovation in women's health, and British syringe-free vaccine maker set to shake up the industry

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Ansley Kahn
GHTC
Read More
Four Takeaways from WHA 72
May 30, 2019

Four Takeaways from WHA 72

Against a backdrop of mounting global health challenges, the 72nd World Health Assembly (WHA) convened last week, with politicians, philanthropists, business executives, and civil society leaders all descending upon Geneva. GHTC was on the scene—attending side events, technical briefings, and following the official agenda. Here are our top four takeaways from this year’s assembly.

Philip Kenol GHTC
Read More
Research Roundup: WHO unveils online resource to guide neglected disease R&D, major funding announcements for snakebite research, and TB Alliance awarded grants to develop TB drug candidates
PATH/Gabe Bienczycki
May 20, 2019

Research Roundup: WHO unveils online resource to guide neglected disease R&D, major funding announcements for snakebite research, and TB Alliance awarded grants to develop TB drug candidates

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Ansley Kahn
GHTC
Read More
Research Roundup: Warning to address drug-resistant TB, a new Ebola vaccine strategy in DRC, and FDA takes step to bolster research on pregnant and lactating women
PATH/Georgina Goodwin
May 13, 2019

Research Roundup: Warning to address drug-resistant TB, a new Ebola vaccine strategy in DRC, and FDA takes step to bolster research on pregnant and lactating women

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Ansley Kahn
GHTC
Read More
Innovating the way towards UHC at WHA
PATH/Gabe Bienczycki
May 10, 2019

Innovating the way towards UHC at WHA

Universal health coverage (UHC) will take center stage at the World Health Assembly later this month. While there are many building blocks to achieve UHC, one integral pillar that is too often overlooked is innovation—the creation of new and improved drugs, vaccines, and diagnostic tools. Global health research and development is indispensable in delivering on the vision of quality health for all.

Philip Kenol GHTC
Read More
Members of Congress push back at President’s budget cuts to global health research
April 26, 2019

Members of Congress push back at President’s budget cuts to global health research

The Trump administration’s budget request for fiscal year 2020 (FY20) includes cuts that—if enacted—would hamstring the research and development (R&D) of new global health technologies. Since the release of the budget request in early March, however, lawmakers from both parties have expressed their commitment to shielding critical funding strings from the president’s scissors.

Julien Rashid GHTC
Read More
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • Next
advancing innovation to save lives

© 2009–2021, PATH, as secretariat of the Global Health Technologies Coalition.
Header Photo: PATH/Evelyn Hockstein

  • Stay Informed
  • Join Us
  • Contact Us
  • GHTC Member Log In